↓ Skip to main content

Cochrane Database of Systematic Reviews

Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease

Overview of attention for article published in Cochrane database of systematic reviews, June 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
googleplus
1 Google+ user

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
191 Mendeley
Title
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
Published in
Cochrane database of systematic reviews, June 2013
DOI 10.1002/14651858.cd005226.pub3
Pubmed ID
Authors

Johannes Brettschneider, Jerome Kurent, Albert Ludolph

Abstract

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is the most common neurodegenerative disorder of the motor system in adults. Pain in ALS is a frequent symptom especially in the later stages of disease and can have a pronounced influence on quality of life and suffering. Treatment of pain therefore should be recognised as an important aspect of palliative care in ALS. This is an update of a review first published in 2008.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 <1%
Unknown 190 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 14%
Student > Bachelor 21 11%
Student > Ph. D. Student 19 10%
Researcher 15 8%
Student > Doctoral Student 15 8%
Other 47 25%
Unknown 48 25%
Readers by discipline Count As %
Medicine and Dentistry 77 40%
Unspecified 14 7%
Nursing and Health Professions 13 7%
Psychology 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Other 21 11%
Unknown 53 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2013.
All research outputs
#13,385,646
of 22,711,645 outputs
Outputs from Cochrane database of systematic reviews
#10,076
of 12,313 outputs
Outputs of similar age
#104,113
of 197,554 outputs
Outputs of similar age from Cochrane database of systematic reviews
#232
of 288 outputs
Altmetric has tracked 22,711,645 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,313 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,554 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 288 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.